Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease

doi:10.4254/wjh.v18.i1.113475

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

(43)

(36)

(0)

(15)

(1)

(901)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Jan 27, 2026; 18(1): 113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475

Table 3 Comparison of different indices by gender

Indices	Male	Female	P value
FIB-4	1.64 (0.83-3.15)	1.59 (0.94-2.54)	0.560
NLR	1.90 (1.54-2.81)	2.19 (1.12-3.21)	0.632
PLR	142.5 (98.2-189.7)	139.7 (102.4-178.3)	0.781
NPAR	14.13 (12.20-17.14)	14.04 (11.80-16.56)	0.793
APRI	1.23 (0.25-2.21)	1.09 (0.22-1.96)	0.297
CAP	270.00 (223-302)	273.00 (243.00-302.00)	0.642
Liver stiffness	9.30 (5.40-26.80)	4.80 (4.40-7.60)	0.002

FIB-4: Fibrosis index based on four factors; APRI: Aspartate transaminase to platelet ratio index; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; NPAR: Neutrophil percentage-to-albumin ratio; CAP: Controlled attenuation parameter.

Full Size Table

Citation: Joseph A, Mathew S, Nair HR. Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 113475
URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113475.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113475

Joseph A, Mathew S, Nair HR. Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 113475 [PMID: 41640950 DOI: 10.4254/wjh.v18.i1.113475]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.